Covidien Public Limited Company develops, manufactures, and sells healthcare products for use in clinical and home settings in the United States and internationally. Its Medical Devices segment offers endomechanical instruments, such as laparoscopic instruments and surgical staplers; energy devices, which include vessel sealing, electrosurgical, and ablation products and related capital equipment; and soft tissue repair products comprising sutures, mesh, biosurgery products, and hernia mechanical devices. This segment also provides vascular products, including compression, dialysis, venous insufficiency, thrombectomy, neurovascular, and peripheral vascular products; oximetry and monitoring products, such as sensors, monitors, and temperature management products; and airway and ventilation products, which include airway, ventilator, breathing systems, and inhalation therapy products. The company’s Pharmaceuticals segment provides branded and generic pharmaceuticals, including pain and addiction treatment products; active pharmaceutical ingredients comprising medicinal opiates, peptides, stearates, and phosphate; contrast products, such as contrast delivery systems and contrast agents; and radiopharmaceuticals, including radioactive isotopes and associated pharmaceuticals used for the diagnosis and treatment of diseases. Its Medical Supplies segment offers nursing care products, which include incontinence, wound care, enteral feeding, urology, and suction products; medical surgical products, such as operating room supply products related accessories, electrodes, thermometry, and chart paper product lines; sharp safety products comprising needles, syringes, and sharps disposal products; and original equipment manufacturer products. The company markets its products through direct sales force and third-party distributors primarily to hospitals, surgi-centers, alternate site facilities, and drug manufacturers. Covidien Public Limited is based in Dublin, Ireland.